ArTS Archivio della ricerca di Trieste

FANIN, RENATO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.719
AS - Asia 1.072
EU - Europa 928
SA - Sud America 49
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.782
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.708
SG - Singapore 496
SE - Svezia 423
HK - Hong Kong 314
CN - Cina 187
RU - Federazione Russa 115
BG - Bulgaria 84
IE - Irlanda 81
DE - Germania 66
IT - Italia 42
FR - Francia 36
BR - Brasile 35
KR - Corea 27
BE - Belgio 15
GB - Regno Unito 12
TR - Turchia 12
FI - Finlandia 10
IN - India 10
NL - Olanda 10
CA - Canada 9
SN - Senegal 8
CH - Svizzera 7
UA - Ucraina 7
AT - Austria 6
PL - Polonia 5
AR - Argentina 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
PE - Perù 3
TW - Taiwan 3
BO - Bolivia 2
CL - Cile 2
ID - Indonesia 2
IL - Israele 2
JP - Giappone 2
KG - Kirghizistan 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CR - Costa Rica 1
EE - Estonia 1
EG - Egitto 1
ES - Italia 1
GA - Gabon 1
GE - Georgia 1
IQ - Iraq 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MA - Marocco 1
NP - Nepal 1
PH - Filippine 1
PK - Pakistan 1
PY - Paraguay 1
RS - Serbia 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 5.782
Salva come PNG Salva come JPEG
Città #
Fairfield 615
Singapore 369
Ashburn 332
Hong Kong 314
Woodbridge 277
Chandler 257
Wilmington 241
Houston 236
Seattle 236
Cambridge 207
Princeton 166
Boardman 153
Ann Arbor 137
Beijing 87
Santa Clara 86
Jacksonville 85
Sofia 84
Dublin 81
Columbus 77
Moscow 51
San Diego 44
Seoul 27
Düsseldorf 24
Frankfurt am Main 19
Lauterbourg 16
Brussels 15
Trieste 14
Los Angeles 13
Norwalk 13
Washington 10
Bremen 9
Dakar 8
Helsinki 8
Andover 7
Monmouth Junction 7
Portsmouth 7
Bern 6
Fremont 6
Nanjing 6
Pune 6
Toronto 6
Kocaeli 5
Shanghai 5
São Paulo 5
Vienna 5
Kunming 4
The Dalles 4
Tianjin 4
Ankara 3
Augusta 3
Casier 3
Dallas 3
Hebei 3
Hefei 3
Lima 3
Mumbai 3
Redwood City 3
Shenyang 3
Warsaw 3
Bishkek 2
Brno 2
Franco da Rocha 2
Fuzhou 2
Guangzhou 2
Haikou 2
Jinan 2
La Paz 2
Lappeenranta 2
Leawood 2
London 2
Milan 2
Naples 2
Padova 2
Pelotas 2
Redmond 2
San Jose 2
San Mateo 2
Taiyuan 2
Tappahannock 2
Wenzhou 2
Albuquerque 1
Almaty 1
Araguaína 1
Asunción 1
Baku 1
Basra 1
Belgrade 1
Belo Horizonte 1
Belém 1
Bexley 1
Binangonan 1
Brasília 1
Buenos Aires 1
Buffalo 1
Cairo 1
Canaã dos Carajás 1
Cangzhou 1
Castro Valley 1
Changchun 1
Changsha 1
Totale 4.489
Salva come PNG Salva come JPEG
Nome #
Low-dose rituximab in adult patients with primary immune thrombocytopenia 127
Rituximab for the treatment of type II mixed cryoglobulinemia 121
Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma 118
Efficacy of selective B cell Blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells 112
Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation 104
Rituximab in a case of cold agglutinin disease 103
Acute hepatic failure as onset of progressive sclerodermatous chronic graft-versus-host disease after donor lymphocyte infusion 103
Efficacy and safety of rituximab in type II mixed cryoglobulinemia 102
Bendamustine in chronic lymphocytic leukemia: Outcome according to different clinical and biological prognostic factors in the everyday clinical practice 102
Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia 101
CHOP-rituximab with pegylated liposomal doxorubicin for the treatment of elderly patients with diffuse large B-cell lymphoma 100
Prognostic significance of delayed thrombocytopenia after allogeneic stem cell transplant 98
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia 98
Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases 97
Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response 97
Bendamustine salvage therapy for T cell neoplasms 96
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia 96
Activity of all-trans-retinoic acid in a case of central nervous system extramedullary relapse of acute promyelocytic leukemia 94
Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results 93
The genotype of the hepatitis C virus in patients with HCV-related B cell non-Hodgkin's lymphoma 93
Management of immune thrombocytopenia in elderly patients 91
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi 90
Surgical staging in Hodgkin's disease: the role of laparoscopic splenectomy 90
Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab 89
Earlier administration of Rituximab allows higher rate of long-lasting response in adult patients with autoimmune thrombocytopenia 85
Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation 84
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: correlations with clinicobiologic parameters 83
Treatment of refractory chronic GVHD with rituximab: a GITMO study 83
Long-lasting complete remission of hepatitis C virus (HCV) infection and HCV-associated immunocytoma with alpha-interferon treatment 82
Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: A phase II clinical trial of the fondazione italiana linfomi 80
BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine 80
Paraneoplastic cerebellar degeneration associated with anti-neuronal anti-Tr antibodies in a patient with Hodgkin's disease 79
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 79
Meningeal and cerebral involvement in multiple myeloma patients 78
T-cell chimerism and clinical outcome after reduced-intensity conditioning allogeneic stem cell transplantation 77
Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma 76
Autologous stem cell transplantation for Hodgkin's lymphoma: results and prognostic factors in 51 high-risk patients 76
Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura 75
Hepatitis C virus infection (and additional neoplasms) among marginal zone lymphomas 73
B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia 73
Nocardiosis with favourable clinical outcome in progressive B-chronic lymphocytic leukaemia 72
Brentuximab vedotin in combination with extended field radiotherapy as salvage treatment for primary refractory Hodgkin lymphoma 71
CD38, BCL-2, PD-1 and PD-1L expression in nodal peripheral T-cell lymphoma (PTCL): Possible biomarkers for novel targeted therapies? 71
A retrospective analysis of 144 patients with aggressive non-Hodgkin's lymphoma: impact of aurtologoaus stem cell transplantation in first remission on autcome 71
New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment? 70
Endogenous endophthalmitis following disseminated fungemia due to Fusarium solani in a patient with acute myeloid leukemia 68
Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma 67
The therapy of primary adult systemic CD30-positive anaplastic large cell lymphoma: results of 40 cases treated in a single center 67
Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin’s lymphomas 66
B-cell compartment as the selective target for the treatment of immune thrombocytopenias 65
The role of granulocyte colony-stimulating factor (filgrastim) in maintaining dose intensity during conventional-dose chemotherapy with ABVD in Hodgkin's disease 65
Risk of C virus infection in Waldenstrom’s syndromes and monoclonal gammopathies 64
Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi 64
Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: Results of a retrospective, observational GIMEMA study 64
Computed tomography, magnetic resonance and gallium 67 scintigraphy for the imaging of residual lymphoma 63
The role of Rituximab in the therapy of mixed cryoglobulinemia 61
Hepatitis C virus and lymphoproliferative disorders 60
Intensified full-dose induction therapy (HD-MACHOP+radiotherapy) follwed dy consolidation with BAVC regimen and autologous stem cell transplantation as fron-line therapeutic approach for high risk aggressive non Hodgkin lymphoma 59
Sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)--positive anaplastic large cell lymphoma in adults 59
Prevalence of Hepatitis C Virus infection in patients with lymphoproliferative disorder 59
Pixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomas 58
Primary systemic CD30 (Ki-1)-positive anaplastic large cell lymphoma of the adult: sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous bone marrow transplantation 58
Clinical features and outcome of multiple myeloma arising from the transformation of a monoclonal gammapathy of undetermined significance 57
High-dose therapy in multiple myeloma: effect of positive selection of CD34+ peripheral blood stem cells on hematologic engraftment and clinical outcome 56
Two cases of concomitant diffuse large B-cell lymphoma and myelodysplastic syndrome 54
High-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's lymphoma: a single center experience 53
Granulocyte colony-stimulating factor (G-CSF) allows the delivery of effective doses of CHOP and CVP regimens in non-Hodgkin lymphomas 52
Retrospective analysis of 34 cases of hairy cell leukemia treated with interferon-alpha and/or 2-chlorodeoxyadenosine 50
Retrospective analysis of 23 cases with peripheral T-cell lymphoma, unspecified: clinical characteristics and outcome 50
No evidence for B-cell clonality by spectratyping analysis in patients with idiopathic thrombocytopenic purpura undergoing rituximab therapy” 47
Predicting lymphoma in Sjögren's syndrome and the pathogenetic role of parotid microenvironment through precise parotid swelling recording 46
The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery 46
Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies 45
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers 44
Thalidomide before autologous stem cell transplantation in VAD-refractory multiple myeloma patients 44
Effect on survival of the development of late-onset non-infectious pulmonary complications after stem cell transplantation 44
Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome 43
Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab 38
Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study 36
Myasthenia gravis after allogeneic bone marrow transplantation: a case report 36
The F-MACHOP regimen in the treatment of aggressive non-Hodgkin’s lymphomas: a single centre experience in 72 patients 34
Neutralizing anti-interferon-alpha antibodies and response to treatment in patients with Ph+ chronic myeloid leukaemia sequentially treated with recombinant (alpha 2a) and lymphoblastoid interferon-alpha 34
Myasthenia gravis after allogeneic bone marrow transplantation. A case report and a review of the literature 28
Occurrence of multiple myeloma after fludarabine treatment of a chronic lymphocytic leukemia: evidence of a biclonal derivation and clinical response to autologous transplantation 28
Early chemosensitivity to VAD regimen predicts a favorable outcome after autologous stem cell transplantation in multiple myeloma 27
Totale 6.092
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.045
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.045
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020190 0 0 0 0 0 0 0 0 0 86 51 53
2020/20211.093 57 136 113 103 82 127 22 89 15 102 66 181
2021/2022937 17 106 2 131 4 23 49 32 113 73 38 349
2022/2023971 117 127 102 60 101 191 1 104 114 17 32 5
2023/2024689 28 29 69 15 33 94 122 181 30 10 44 34
2024/20251.262 3 242 273 98 111 134 76 70 112 143 0 0
Totale 6.092